Blue Jet Healthcare, a company in the Pharmaceuticals industry, reported revenue of ₹376 crore and net profit of ₹103 crore for the September 2026 quarter.
Blue Jet Healthcare (NSE: BLUEJET) closed at ₹517.60 on 20 Nov 2026, down 10.4% over the past year. Its market capitalisation is ₹9,797 crore and it trades at 34.3 times earnings.
Incorporated in 1968, Blue Jet Healthcare (earlier called Jet Chemicals Pvt Ltd) is a pharmaceutical and healthcare ingredient & intermediate company and the first manufacturer of saccharin and its salts (artificial sweeteners) in India.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.